MwanzoPHIO • NASDAQ
add
Phio Pharmaceuticals Corp
$ 2.18
Baada ya Saa za Kazi:(0.46%)+0.0100
$ 2.19
Imefungwa: 12 Sep, 20:00:00 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 2.32
Bei za siku
$ 2.15 - $ 2.32
Bei za mwaka
$ 0.97 - $ 9.79
Thamani ya kampuni katika soko
12.48M USD
Wastani wa hisa zilizouzwa
elfu 157.05
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 1.24M | 17.84% |
Mapato halisi | -2.17M | -17.33% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | — | — |
EBITDA | -2.31M | -20.67% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 10.78M | 129.35% |
Jumla ya mali | 11.30M | 113.39% |
Jumla ya dhima | 1.21M | -20.81% |
Jumla ya hisa | 10.10M | — |
hisa zilizosalia | 5.73M | — |
Uwiano wa bei na thamani | 1.10 | — |
Faida inayotokana na mali | -46.66% | — |
Faida inayotokana mtaji | -51.85% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -2.17M | -17.33% |
Pesa kutokana na shughuli | -2.54M | -42.94% |
Pesa kutokana na uwekezaji | elfu -3.00 | — |
Pesa kutokana na ufadhili | elfu 40.00 | — |
Mabadiliko halisi ya pesa taslimu | -2.50M | -40.86% |
Mtiririko huru wa pesa | -1.82M | -61.47% |
Kuhusu
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Ilianzishwa
2011
Tovuti
Wafanyakazi
5
